Deepak S. Nath is President & VP at ABBOTT LABORATORIES (ABT). They have made 2 open-market trades across 1 company since 2016, most recently 2017-04-28.
CIK 0001636628
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 51,241 | $5.4M |
Shares reported on the most recent Form 4, priced at the 2017-05-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2017-03-01 | 2017-03-02 | $45.39 | $145K | -1.4% | -2.1% | +0.5% |
| ABT | SELL · 10b5-1 | 2017-02-21 | 2017-02-22 | $44.98 | $14K | +0.2% | -0.6% | -3.0% |
| ABT | SELL · 10b5-1 | 2016-04-28 | 2016-04-29 | $41.31 | $2K | -2.2% | +2.0% | +14.4% |
| ABT | SELL · 10b5-1 | 2016-02-29 | 2016-03-02 | $39.27 | $31K | +5.0% | +9.4% | +2.8% |
| ABT | SELL | 2016-02-22 | 2016-02-23 | $39.10 | $12K | +2.6% | +6.7% | -2.1% |
| ABT | SELL · 10b5-1 | 2016-02-16 | 2016-02-17 | $37.13 | $6K | +1.0% | +6.4% | -1.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.